Publication | Closed Access
A Multicenter Phase II Study of the Combination of Irinotecan and Gemcitabine in Previously Treated Patients with Small-Cell Lung Cancer
16
Citations
20
References
2004
Year
The combination showed modest activity in this patient group with a poor prognosis. Thus we believe it merits further investigation in the treatment of patients with small-cell lung cancer who have failed one prior chemotherapy regimen.
| Year | Citations | |
|---|---|---|
Page 1
Page 1